Innovasan awarded DOD SBIR Research Contract

“We have successfully completed proof of principle and preliminary design configuration studies for two of the three primary cycles in our patented Med-San® process.”

For Immediate Release
Release Date:
Monday, January 13, 2014
 
Knoxville, TN – Innovasan has received a Department of Defense Small Business Innovation Research (DoD SBIR) Award from the Telemedicine and Advanced Technology Research Center (TATRC), U.S. Army Medical Research and Materiel Command (USAMRMC), Ft. Detrick, MD. in response to its solicitation for an “Innovative Lightweight Energy and Water Efficient Treatment System for Fluid Medical Waste”.

A SBIR Project Kick-Off Meeting was hosted by TATRC last week to discuss the Army’s targeted technology requirements, the Phase I research award and introduce the network of technical assistance services available to support Innovasan through the SBIR program phases.  The ultimate goal of Innovasan’s SBIR initiative is to field a medical waste treatment system for the military that can be successfully commercialized to meet to growing global civilian demand for a technology alternative to current fluid medical waste disposal practices.  The Phase I Award will enable Innovasan to complete ongoing wet oxidation proof of principle studies for its patented continuous flow, volume scalable Med-San® fluid medical waste treatment process. 

“We have successfully completed proof of principle and preliminary design configuration studies for two of the three primary cycles in our patented Med-San® process.  Wet oxidation is the final primary cycle to undergo proof of principle and with its completion we will be able to move forward with the integration of the entire Med-San® process into the M50 Interceptor Waste Treatment System® prototype. The TATRC trip provided us with invaluable feedback that will help drive the M50’s final design configuration and deliver a better product for our military,” said Jeff Hubrig Jr., Manager of Business Development. 

This work is supported by the US Army Medical Research and Materiel Command under Contract No. W81XWH-14-C-0026. The views, opinions and/or findings contained in this report are those of the authors and should not be construed as an official Department of the Army position, policy or decision unless so designated by other documentation.